Abstract
The type-1 insulin-like growth-factor receptor (IGF-1R) and insulin receptor (IR) are closely related members of the tyrosine-kinase receptor superfamily1. IR is essential for glucose homeostasis2, whereas IGF-1R is involved in both normal growth and development and malignant transformation3. Homologues of these receptors are found in animals as simple as cnidarians4. The epidermal growth-factor receptor (EGFR) family is closely related to the IR family and has significant sequence identity to the extracellular portion we describe here. We now present the structure of the first three domains of IGF-1R (L1–Cys-rich–L2) determined to 2.6 Å resolution. The L domains each consist of asingle-stranded right-handed β-helix. The Cys-rich region is composed of eight disulphide-bonded modules, seven of which form a rod-shaped domain with modules associated in an unusual manner. The three domains surround a central space of sufficient size to accommodate a ligand molecule. Although the fragment (residues 1–462) does not bind ligand, many of the determinants responsible for hormone binding and ligand specificity map to this central site. This structure therefore shows how the IR subfamily might interact with their ligands.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 51 print issues and online access
$199.00 per year
only $3.90 per issue
Rent or buy this article
Prices vary by article type
from$1.95
to$39.95
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Ullrich, A. et al. Insulin-like growth factor 1 receptor primary structure: comparison with insulin receptor suggests structural determinants that define functional specificity. EMBO J. 5, 2503–2512 (1986).
De Meyts, P. The structural basis of insulin and insulin-like growth factor-I receptor binding and negative co-operativity, and its relevance to mitogenic versus metabolic signalling. Diabetologia 37, 135–148 (1994).
Baserga, R. Controlling IGF-receptor function: a possible strategy for tumor therapy. Trends Biotechnol. 14, 150–152 (1996).
Steele, R. E., Lieu, P., Mai, N. H., Shenk, M. A. & Sarras, M. P. J Response to insulin and the expression pattern of a gene encoding an insulin receptor homologue suggest a role for an insulin-like molecule in regulating growth and patterning in Hydra. Dev. Genes. Evol. 206, 247–259 (1996).
Torres, A. M. et al. Solution structure of human insulin-like growth factor II—relationship to receptor and binding protein interactions. J. Mol. Biol. 248, 385–401 (1995).
Schaefer, E. M., Siddle, K. & Ellis, L. Deletion analysis of the human insulin receptor ectodomain reveals independently folded soluble subdomains and insulin binding by a monomeric α-subunit. J.Biol. Chem. 265, 13248–13253 (1990).
Mynarcik, D. C., Yu, G. Q. & Whittaker, J. Alanine-scanning mutagenesis of a C-terminal ligand binding domain of the insulin receptor alpha subunit. J. Biol. Chem. 271, 2439–2442 (1996).
McKern, N. M. et al. Crystallization of the first three domains of insulin-like growth factor I receptor. Protein Sci. 6, 2663–2666 (1997).
Taylor, S. I. et al. Mutations in the insulin receptor gene: update 1994. Endocr. Rev. 2, 58–65 (1994).
Bajaj, M., Waterfield, M. D., Schlessinger, J., Taylor, W. R. & Blundell, T. On the tertiary structure of the extracellular domains of the epidermal growth factor and insulin receptors. Biochim. Biophys. Acta 916, 220–226 (1987).
Ward, C. W., Hoyne, P. A. & Flegg, R. H. Insulin and epidermal growth factor receptors contain the cysteine repeat motif found in the tumour necrosis factor receptor. Proteins Struct. Funct. Genet. 22, 141–153 (1995).
Holm, L. & Sander, S. Protein structure comparison by alignment of distance matrices. J. Mol. Biol. 233, 123–138 (1993).
Kobe, B. & Deisenhofer, J. Proteins with leucine-rich repeats. Curr. Opin. Struct. Biol. 5, 409–416 (1995).
Yoder, M. D., Lietzke, S. E. & Jurnak, F. Unusual structural features in the parallel β-helix in pectate lyases. Structure 1, 241–251 (1993).
Stetefeld, J., Mayer, U., Timpl, R. & Huber, R. Crystal structure of three consecutive laminin-type epidermal growth factor-like (LE) modules of laminin gamma-1 chain harboring the nidogen binding site. J. Mol. Biol. 257, 644–657 (1996).
Taylor, S. I. Lilly lecture: molecular mechanisms of insulin resistance. Lessons from patients with mutations in the insulin receptor gene. Diabetes 41, 1473–1490 (1992).
Williams, P. F., Mynarcik, D. C., Yu, G. Q. & Whittaker, J. Mapping of an NH2-terminal ligand binding site of the insulin receptor by alanine scanning mutagenesis. J. Biol. Chem. 270, 3012–3016 (1995).
Kjeldsen, T. et al. Ligand specificities of insulin receptor and the insulin-like growth factor I receptor reside in different regions of a common binding site. Proc. Natl Acad. Sci. USA 88, 4404–4408 (1991).
Schäffer, L. et al. Interactions of a hybrid insulin-like growth factor-I analog with chimeric insulin/Type I insulin-like growth factor receptors. J. Biol. Chem. 268, 3044–3047 (1993).
Gustafson, T. A. & Rutter, W. J. The cysteine-rich domains of the insulin and insulin-like growth factor I receptors are primary determinants of hormone binding specificity. J. Biol. Chem. 265, 18663–18667 (1990).
1. Kurose, T. et al. Cross-linking of a B25 azidophenylalanine insulin derivative to the carboxy-terminal regional of the alpha-subunit of the insulin receptor. Identification of a new insulin-binding domain in the insulin receptor. J. Biol. Chem. 269, 29190–29197 (1994).
Bayne, M. L. et al. The C-region of human insulin-like growth factor (IGF) I is required for high affinity binding to the type I IGF receptor. J. Biol. Chem. 264, 11004–11008 (1988).
Roach, P. et al. Anovel human insulin receptor gene mutation uniquely inhibits insulin binding without impairing posttranslational processing. Diabetes 43, 1096–1102 (1994).
Otwinowski, Z. & Minor, W. Processing of X-ray diffraction data collected in oscillation mode. Methods Enzymol. 276, 307–326 (1996).
Steigeman, W. Dissertation, Technical Univ. Munich (1974).
Cowtan, K. DM: an automated procedure for phase improvement by density modification. Joint CCP4 and ESF-EACBM newslett. Protein Crystallogr. 31, 34–38 (1994).
Jones, T. A., Cowan, S., Zou, J.-Y. & Kjeldgaard, M. Improved methods for building protein models in electron density maps and the location of errors in these models. Acta Crystallogr. A 47, 110–119 (1991).
Brunger, A. T. X-PLOR reference manual 3.851 (Yale Univ., New Haven, CT, 1996).
Murshudov, G. N., Vagin, A. A. & Dodson, E. Refinement of macromolecular structures by the maximum-likelihood method. Acta Crystallogr. D 53, 240–255 (1997).
Nakae, J., Morioka, H., Ohtsuka, E. & Fujieda, K. Replacements of leucine 87 in human insulin receptor alter affinity for insulin. J. Biol. Chem. 270, 22017–22022 (1995).
Acknowledgements
Financial support was provided under the Generic Technology component of the Industry Research and Development Act 1986 and from Biota Diabetes Research Pty. We thank P. M. Colman for support and discussions.
Author information
Authors and Affiliations
Corresponding authors
Rights and permissions
About this article
Cite this article
Garrett, T., McKern, N., Lou, M. et al. Crystal structure of the first three domains of the type-1 insulin-like growth factor receptor. Nature 394, 395–399 (1998). https://doi.org/10.1038/28668
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1038/28668
This article is cited by
-
Structural basis of the activation of type 1 insulin-like growth factor receptor
Nature Communications (2019)
-
How ligand binds to the type 1 insulin-like growth factor receptor
Nature Communications (2018)
-
The genome of the largest bony fish, ocean sunfish (Mola mola), provides insights into its fast growth rate
GigaScience (2016)
-
Pressuromodulation at the cell membrane as the basis for small molecule hormone and peptide regulation of cellular and nuclear function
Journal of Translational Medicine (2015)
-
How insulin engages its primary binding site on the insulin receptor
Nature (2013)
Comments
By submitting a comment you agree to abide by our Terms and Community Guidelines. If you find something abusive or that does not comply with our terms or guidelines please flag it as inappropriate.